Family · Pharmaceutical analytical standards
Spironolactone
A steroidal aldosterone antagonist discovered in 1957 and introduced in 1959; it is a potassium-sparing diuretic used for heart failure, resistant hypertension, fluid build-up from liver or kidney disease and low potassium. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.
Did you know?The name describes its structure: "spiro" means that a lactone ring is attached to the steroid skeleton through a single shared atom, a so-called spiro junction.
No product matches your search.
EDQM standards 1
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
